Stem definition | Drug id | CAS RN |
---|---|---|
5150 | 530-43-8 |
None
Property | Value | Reference |
---|---|---|
BA (Bioavailability) | 80 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
Date | Agency | Company | Orphan |
---|---|---|---|
None | FDA |
None
None
None
None
Source | Code | Description |
---|---|---|
FDA EXT | N0000175479 | Amphenicols |
FDA EPC | N0000175480 | Amphenicol-class Antibacterial |
MeSH PA | D000900 | Anti-Bacterial Agents |
MeSH PA | D000890 | Anti-Infective Agents |
MeSH PA | D004791 | Enzyme Inhibitors |
MeSH PA | D011500 | Protein Synthesis Inhibitors |
CHEBI has role | CHEBI:33281 | antibiotics |
CHEBI has role | CHEBI:36047 | antibacterial drugs |
CHEBI has role | CHEBI:48001 | protein synthesis inhibitors |
CHEBI has role | CHEBI:76971 | Escherichia coli metabolites |
CHEBI has role | CHEBI:131604 | Mycoplasma genitalium metabolites |
CHEBI has role | CHEBI:176497 | geroprotectors |
None
Species | Use | Relation |
---|---|---|
Cats | Bacterial conjunctivitis | Indication |
Dogs | Respiratory tract infections | Indication |
Dogs | Urinary tract infections | Indication |
Dogs | Bacterand enteritis | Indication |
Dogs | Tonsillitis | Indication |
Product | Applicant | Ingredients |
---|---|---|
Chloromycetin Palmitate Oral Suspension | Zoetis Inc. | 1 |
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 10.37 | acidic |
None
None
None
ID | Source |
---|---|
43VU4207NW | UNII |
4018199 | VANDF |
4018201 | VANDF |
C0055337 | UMLSCUI |
CHEBI:3605 | CHEBI |
CHEBI:17698 | CHEBI |
CLM | PDB_CHEM_ID |
CHEMBL1506 | ChEMBL_ID |
D01072 | KEGG_DRUG |
443382 | PUBCHEM_CID |
DB14658 | DRUGBANK_ID |
20767 | RXNORM |
20707 | MMSL |
3887 | MMSL |
4406 | MMSL |
73105 | MMSL |
d00025 | MMSL |
002767 | NDDF |
002768 | NDDF |
29327006 | SNOMEDCT_US |
372777009 | SNOMEDCT_US |
57191001 | SNOMEDCT_US |
C0008168 | UMLSCUI |
DB00446 | DRUGBANK_ID |
977 | INN_ID |
D002701 | MESH_DESCRIPTOR_UI |
C030578 | MESH_SUPPLEMENTAL_RECORD_UI |
5959 | PUBCHEM_CID |
None